Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking Dan Loeb’s Third Point Portfoli...
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking John Paulson’s Paulson & Co...
VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to announce that it has subm...
Breakthrough genome editing companies including Editas (NASDAQ: EDIT) and Intellia Therapeutics (NASDAQ: NTLA) have been in a tailspin since late 2019, and the latest earnings reports from both of those companies show that their revenue from collaborations and partnerships has start...
Editors' Note: This is the transcript of the video we posted Friday. Please note that due to time and audio constraints, transcription may not be perfect. We encourage you to listen to the video as well as a podcast embedded below if you need any clarification. We hope you enjoy. Daniel...
This article is part of a series that provides an ongoing analysis of the changes made to David Abrams’ 13F portfolio on a quarterly basis. It is based on Abrams’ regulatory 13F Form filed on 05/14/2020. Please visit our Tracking David Abrams’ Abrams Capital Management ...
Friday I stuck my neck out and got bullish because the charts told me so Naturally, I am now on guard for how the stock market will make a fool of me, since that’s what happens 60% or more of the time, or so it feels. Since the markets are closed, I like to summarize information fro...
Introduction AbbVie ( ABBV ) and Allergan ( AGN ) announced their plans to merge on June 25, 2019. Initial market reaction was negative with a nearly 10% drop in the two days following the announcement, followed by a bounce and an even bigger drop, bottoming out in mid-August. Not long aft...
Merger activity increased last week with three new deals announced, four deals closing and one deal terminated. After a three-week lull, merger activity picked up again with three new deals announced. The hard-hit energy services industry saw the merger of KLX Energy Services Holdings (KLX...
The COVID-19 pandemic is still far from over, and many investors are increasingly looking for stability in a highly volatile stock market. And while no industry has been entirely immune to the adverse effects of the outbreak, some pharmaceutical companies have managed to handle the ongoing crisi...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...